Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

TTC30A2 Inhibitors

TTC30A2 inhibitors are a class of chemical compounds that specifically target and inhibit the function of the Tetratricopeptide Repeat Domain 30A2 (TTC30A2) protein. TTC30A2 belongs to the tetratricopeptide repeat (TPR) family, which is characterized by its TPR motifs that mediate protein-protein interactions. TTC30A2 is known to play a significant role in regulating the structure and function of cilia, the hair-like organelles that protrude from the surface of many eukaryotic cells. TTC30A2 is involved in the assembly and stabilization of the axoneme, the core structural component of cilia, and is crucial for proper ciliary function, including movement and signal transduction. By inhibiting TTC30A2, these compounds interfere with the protein's ability to maintain cilia structure and function, potentially leading to disruptions in ciliary assembly or movement.

Structurally, TTC30A2 inhibitors are designed to bind to the TPR motifs or other regions critical for the protein's interactions with other ciliary components or molecular chaperones. This binding blocks TTC30A2's ability to form or stabilize protein complexes necessary for ciliary function. These inhibitors provide valuable tools for studying the role of TTC30A2 in cilia formation, maintenance, and motility, allowing researchers to better understand the protein's contribution to cellular organization and signaling pathways. Through the use of TTC30A2 inhibitors, scientists can investigate how the disruption of cilia-related processes affects cellular behavior, providing insights into broader mechanisms of ciliary function, intracellular transport, and cellular response to external stimuli. By focusing on TTC30A2 inhibition, researchers can deepen their understanding of the essential roles that cilia play in coordinating cellular processes and maintaining structural integrity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$111.00
$357.00
8
(0)

Thalidomide inhibits the expression of intraflagellar transport 70A2 by modulating the activity of cereblon, leading to proteasomal degradation of the protein, thereby reducing its levels.

Lenalidomide

191732-72-6sc-218656
sc-218656A
sc-218656B
10 mg
100 mg
1 g
$50.00
$374.00
$2071.00
18
(1)

Lenalidomide inhibits the expression of intraflagellar transport 70A2 by binding to cereblon and promoting the ubiquitination and subsequent degradation of the protein.

Pomalidomide

19171-19-8sc-364593
sc-364593A
sc-364593B
sc-364593C
sc-364593D
sc-364593E
5 mg
10 mg
50 mg
100 mg
500 mg
1 g
$100.00
$143.00
$312.00
$468.00
$1248.00
$1997.00
1
(1)

Pomalidomide inhibits the expression of intraflagellar transport 70A2 by enhancing the recruitment of cereblon to the protein, leading to its ubiquitination and proteasomal degradation.

MLN 4924

905579-51-3sc-484814
1 mg
$286.00
1
(0)

MLN4924 inhibits the expression of intraflagellar transport 70A2 by inhibiting the activity of NEDD8-activating enzyme, resulting in the stabilization of cullin-RING E3 ligases and subsequent degradation of the protein.

(+)-Nutlin-3

675576-97-3sc-222085
sc-222085A
500 µg
1 mg
$94.00
$122.00
(0)

Nutlin-3 inhibits the expression of intraflagellar transport 70A2 by disrupting the interaction between MDM2 and p53, leading to the activation of p53-mediated transcriptional programs, including the suppression of genes involved in ciliogenesis.

ARP 100

704888-90-4sc-203522
5 mg
$208.00
26
(1)

NSC 319726 inhibits the expression of intraflagellar transport 70A2 by interfering with the interaction between MDM2 and p53, resulting in the activation of p53-dependent transcriptional programs that suppress the expression of genes involved in ciliogenesis, including this protein.

p53 Activator III, RITA

213261-59-7sc-202753
sc-202753A
sc-202753B
sc-202753C
1 mg
10 mg
100 mg
500 mg
$112.00
$273.00
$1564.00
$5205.00
9
(1)

RITA inhibits the expression of intraflagellar transport 70A2 by disrupting the interaction between MDM2 and p53, leading to the stabilization and activation of p53, which suppresses the transcription of genes involved in ciliogenesis, including this protein.

Tenovin-6

1011557-82-6sc-224296
sc-224296A
1 mg
5 mg
$272.00
$1214.00
9
(1)

Tenovin-6 inhibits the expression of intraflagellar transport 70A2 by promoting the acetylation and stabilization of p53, which leads to the activation of p53-dependent transcriptional programs that suppress the expression of genes involved in ciliogenesis, including this protein.